Welcome to ShireCanada.com

Shire Canada Inc. ("Shire Canada"), Shire Regenerative Medicine, Inc. ("Shire Regenerative Medicine") and Shire Human Genetic Therapies (Canada) Inc. ("Shire Human Genetic Therapies (Canada)") are wholly owned subsidiaries of Shire plc, a global specialty biopharmaceutical company that works closely with specialist physicians to develop and market medicines that improve the quality of life for patients, their families and caregivers.

Shire focuses on attention deficit hyperactivity disorder (ADHD), human genetic therapies, diabetic foot ulcers (DFUs) as well as gastrointestinal and renal diseases.

Shire Canada is a proud member of Canada’s Research-Based Pharmaceutical Companies (Rx&D) and MEDEC, the Canadian medical technology industry national association. Shire Human Genetic Therapies (Canada) is a proud member of BIOTECanada.

Shire Canada Inc.
2250 Alfred-Nobel Blvd
Suite 500
Saint-Laurent, QC H4S 2C9
Tel: 514-787-2300
Fax: 514-787-2427
E-Mail: infocanada@shire.com

Shire Human Genetic Therapies (Canada) Inc.
4120 Yonge Street, Suite 404
Toronto, Canada M2P 2B8
Tel: 416-225-6100
Fax: 416-225-6102
E-Mail: infocanada@shire.com